Kite and Gilead UK&I 2024 CAR-T Fellowship and Medical Grants Programme now open

Kite and Gilead UK & Ireland CAR-T Fellowship and Medical Grants Programme

The Kite and Gilead UK and Ireland Fellowship and Medical Grants Programme (GFP) is a medical grants funding stream that supports innovative best practice projects and initiatives that aim to improve the lives of patients.

The 2024 CAR-T Fellowship and Medical Grants Programme is now open and will be accepting applications until 28th June. Applications are invited from healthcare and third sector organisations (e.g., charities) who are seeking funding for a project that aligns with the goals of the programme. The Programme is looking to support projects and initiatives (up to £50,000) which ultimately lead to an improvement in patient care. This can include, but is not limited to, activities such as:

  • Initiatives to facilitate improved efficiency in patient care and shared care pathways between referring and CAR-T treatment centres
  • Audits assessing patient profiles, disease outcomes and treatment patterns
  • Monitoring of patient-reported outcomes, quality of life measures or educational tools for patients and carers
  • New infrastructure/processes established for better diagnosis or detection of disease, or prediction or monitoring of safety and efficacy outcomes to treatment
  • Investigations into better detection and treatment of special patient populations and sub-types

Further information on the 2024 CAR-T Fellowship and Medical Grants Programme can be found on Gilead’s website.

Date of preparation: May 2024

Code: UK-UNB-5542.

 

Latest News

By BOPA Executive Committee on 4th November 2025

Joint BOPA and PASG Position Statement Safer Handling of Hazardous SACT Drugs: A Pharmacy Workforce Position Statement

BOPA and PASG Publish Joint Position Statement on the Safer Handling of Hazardous SACT Drugs The British Oncology Pharmacy Association (BOPA) and the NHS Pharmaceutical Aseptic Services Group (PASG) have…

Read article
By Jennifer Allen - LCC Lead on 4th November 2025

BOPA’s Let’s Communicate Cancer (LCC) series receives re-accreditation from the Royal Society for Public Health (RSPH)

The Let’s Communicate Cancer (LCC) series, available for free on the BOPA website CancerHUB: Home Page – BOPA, has recently received re-accreditation from the Royal Society for Public Health which…

Read article
By BOPA Executive Committee on 3rd November 2025

BOPA’s Submission for the National Cancer Plan for England 2025 – Call for Evidence

With the National Cancer Plan 2025 for England Publication imminent (Shaping the national cancer plan – GOV.UK) – please find BOPA’s Submission for the call for evidence below: BOPA Submission…

Read article
By BOPA IOSIG on 1st November 2025

IOCN UK-wide Survey: Access to Immunosuppressants for ICI Adverse Events

  IOCN UK-wide Survey: Access to Immunosuppressants for ICI Adverse Events Have your say on a critical issue affecting immunotherapy patients across the UK. The IOCN and UKSACT Board have…

Read article